Treatment Outcomes in Type A and B Alcohol Dependence 6 Months After Serotonergic Pharmacotherapy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Evidence supporting the use of serotonergic medications for the treatment of alcohol dependence is available from studies where pharmacotherapy targeted specific alcoholic subtypes. We previously established with Babor's alcohol typology that type A “lower risk/severity” alcoholics (n= 55) had better treatment response to 14 weeks of sertraline (200 mg/day) than placebo, and this was not found for type B “higher risk/severity” alcoholics (n= 45). The purpose of this study was to assess in this original study group whether treatment gains in the type A alcoholics were maintained or whether treatment outcomes changed for the type B alcoholics after discontinuing pharmacotherapy. Methods: After the end of a 3‐month course of 200 mg/day sertraline, the subjects were interviewed at several time points about their alcohol drinking, if any, using the timeline follow‐back method. For 90% of the original study group, mixed effects and generalized estimating equation models were used to compare monthly drinking amounts over a 6‐month posttreatment period with drinking amounts in the last month of treatment. Results: We found that type A alcoholics who had been treated with sertraline, in contrast to placebo, maintained the good outcomes they had achieved during treatment for at least 6 months after pharmacotherapy. We found that type B alcoholics who had been treated with sertraline, in contrast to placebo, continued to show no advantage for pharmacotherapy in the 6 months after completing treatment. In addition, heavy drinking in type B alcoholics increased over the 6 months postpharmacotherapy in those initially treated with sertraline compared with placebo. Conclusions: These data support the importance of considering alcohol subtype when pharmacologically treating alcohol dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
Gmel, G., & Rehm, J. (2004) · Contemporary Drug Problems · doi:10.1177/009145090403100304 · Cited by 466
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444 · cited 2×
“While the overall evidence for treating alcoholics with serotonergic medications has not been as compelling (Garbutt et al., 1999), more recent studies have demonstrated the efficacy of selective serotonin reuptake inhibitors (SSRIs) in specific alcoholic subtypes using Babor's criteria (Babor et…”
BackgroundDrug therapy for alcohol dependence
Swift, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401907 · Cited by 255 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript al., 1999; Johnson et al., 2003; Kranzler and Van Kirk, 2001; Litten and Allen, 1998; Streeton and Whelan, 2001; Swift, 1999).”
BackgroundStreeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript al., 1999; Johnson et al., 2003; Kranzler and Van Kirk, 2001; Litten and Allen, 1998; Streeton and Whelan, 2001; Swift, 1999).”
Background
Cited by
The genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Targeting glutamate uptake to treat alcohol use disorders
Rao, P. S. S., Bell, R. L., Engleman, E. A., & Sari, Y. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00144 · Cited by 136
“In addition, it appears that the pharmacological efficacy of some treatments for AUDs is influenced by the phenotypic and/or genotypic characteristics associated with these typologies (Epstein et al., 1995; Johnson et al., 2003; Cherpitel et al., 2004; Dundon et al., 2004; Johnson,”
BackgroundAntidepressants for the treatment of people with co-occurring depression and alcohol dependence
Agabio, R., Trogu, E., & Pani, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008581.pub2 · Cited by 131
NETER ALCOHOLIC TYPOLOGY (NAT)a
CARDOSO, J. M. N., BARBOSA, A., ISMAIL, F., & POMBO, S. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh247 · Cited by 55
Metadata
- Authors
- Dundon, W., Lynch, K. G., Pettinati, H. M., & Lipkin, C.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2004-07
- Volume
- 28
- Issue
- 7
- Pages
- 1065-1073
- ISSN
- 0145-6008 (ISSN-L)
- 1530-0277
- OpenAlex
- W1977784764
- Cited by
- 77
- References
- 6
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment Outcomes in Type A and B Alcohol Dependence 6 Months After Serotonergic Pharmacotherapy. https://app.cochat.ai/papers/10.1097/01.alc.0000130974.50563.04
- The paper
- Dundon, W., Lynch, K. G., Pettinati, H. M., & Lipkin, C. (2004). Treatment Outcomes in Type A and B Alcohol Dependence 6 Months After Serotonergic Pharmacotherapy. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1097/01.alc.0000130974.50563.04
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.